Evidence map›Paper›PMID 27539542›Full record

ArticleNature communications2016

Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans.

Lesca M Holdt, Anika Stahringer, Kristina Sass, Garwin Pichler, Nils A Kulak, Wolfgang Wilfert, Alexander Kohlmaier, Andreas Herbst, Bernd H Northoff, Alexandros Nicolaou and 8 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03170830 (Study on CircRNA-Uck2 as a New Diagnostic Marker of Acute Myocardial Infarction), which is not on this map. Cited by 664 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
664citing papers in PubMed, 1 pooled it
49.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03170830 naunknown statusnot on this map

Study on CircRNA-Uck2 as a New Diagnostic Marker of Acute Myocardial Infarction

TypeinterventionalSponsorBeijing Haidian HospitalRan2015 to 2018Enrolled178ConditionsCardiac Disease, Diagnoses Disease, Acute Myocardial InfarctionArmsthe diagnosis value of cUck2 in acute myocardial infarction.
3 · Its place in the literature

Who cites it

664 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,134 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. The dark genome in cardiovascular medicine.European heart journal · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Neuroinflammation in glaucoma: a myriad of cellular pathways and players.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

604 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Lesca M HoldtInstitute of Laboratory Medicine, Ludwig-Maximilians-University Munich, 81337 Munich, Germany.
Anika StahringerInstitute of Laboratory Medicine, Ludwig-Maximilians-University Munich, 81337 Munich, Germany.
Kristina SassInstitute of Laboratory Medicine, Ludwig-Maximilians-University Munich, 81337 Munich, Germany.
Garwin PichlerDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Nils A KulakDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Wolfgang WilfertInstitute of Laboratory Medicine, Ludwig-Maximilians-University Munich, 81337 Munich, Germany.
Alexander KohlmaierInstitute of Laboratory Medicine, Ludwig-Maximilians-University Munich, 81337 Munich, Germany.
Andreas HerbstInstitute of Laboratory Medicine, Ludwig-Maximilians-University Munich, 81337 Munich, Germany.
Bernd H NorthoffInstitute of Laboratory Medicine, Ludwig-Maximilians-University Munich, 81337 Munich, Germany.
Alexandros NicolaouInstitute of Laboratory Medicine, Ludwig-Maximilians-University Munich, 81337 Munich, Germany.
Gabor GäbelDepartment of Vascular and Endovascular Surgery, Ludwig-Maximilians-University Munich, 81337 Munich, Germany.
Frank BeutnerLIFE-Leipzig Research Center for Civilization Diseases, Universität Leipzig, 04103 Leipzig, Germany.
Markus ScholzLIFE-Leipzig Research Center for Civilization Diseases, Universität Leipzig, 04103 Leipzig, Germany.
Joachim ThieryLIFE-Leipzig Research Center for Civilization Diseases, Universität Leipzig, 04103 Leipzig, Germany.
Kiran MusunuruDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Knut KrohnLIFE-Leipzig Research Center for Civilization Diseases, Universität Leipzig, 04103 Leipzig, Germany.ORCID 0000-0001-8110-1273
Matthias MannDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Daniel TeupserInstitute of Laboratory Medicine, Ludwig-Maximilians-University Munich, 81337 Munich, Germany.
Ludwig-Maximilians-Universität München · DEMax Planck Institute of Biochemistry · DEUniversity Hospital Leipzig · DELeipzig University · DELeipzig University of Applied Sciences · DEUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are broadly expressed in eukaryotic cells, but their molecular mechanism in human disease remains obscure. Here we show that circular antisense non-coding RNA in the INK4 locus (circANRIL), which is transcribed at a locus of atherosclerotic cardiovascular disease on chromosome 9p21, confers atheroprotection by controlling ribosomal RNA (rRNA) maturation and modulating pathways of atherogenesis. CircANRIL binds to pescadillo homologue 1 (PES1), an essential 60S-preribosomal assembly factor, thereby impairing exonuclease-mediated pre-rRNA processing and ribosome biogenesis in vascular smooth muscle cells and macrophages. As a consequence, circANRIL induces nucleolar stress and p53 activation, resulting in the induction of apoptosis and inhibition of proliferation, which are key cell functions in atherosclerosis. Collectively, these findings identify circANRIL as a prototype of a circRNA regulating ribosome biogenesis and conferring atheroprotection, thereby showing that circularization of long non-coding RNAs may alter RNA function and protect from human disease.

Indexed as

ApoptosisAtherosclerosisCell NucleolusCell ProliferationChromosomes, Human, Pair 9Clustered Regularly Interspaced Short Palindromic RepeatsCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p18Gene Expression ProfilingHEK293 CellsHumansMacrophagesMuscle, Smooth, VascularProteinsRNA-Binding ProteinsCDKN2A protein, humanCDKN2B antisense RNA, humanCDKN2B protein, humanCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p18PES1 protein, humanProteinsRNA-Binding ProteinsRNA, Long NoncodingRNA, Ribosomal

Identifiers

PMID27539542
PMCPMC4992165
OpenAlexW2511152819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.